References
- Ånggård E. Handbook of Experimental Pharmacology, Drug Addiction II, W.R. Martin. Springer-Verlag, Berlin 1977; 45: 3
- Beckett A.H. Xenobiotica 1971; 1: 365
- Braestrup C., Andersen H., Randrup A. Eur. J. Pharmac. 1975; 34: 181
- Birkmayer W., Reiderek P., Ambrozi L., Youdim M.B.H. Lancet 1977; i: 439
- Caldwell J. Drug Metab. Rev. 1976; 5: 219
- Cho A.K., Wright J. Life Sci. 1978; 22: 363
- Csanda E., Antal J., Antony M., Csanaky A. J. Neural Transm. 1978; 43: 263
- Karoum F., Chaung L.-W., Eisler T., Calne D.B., Liebowitz M.R., Quitkin F.M., Klein D.F., Wyatt R.J. Neurology 1982; 32: 503
- Knoll J. Monoamine Oxidase and Its Inhibition, G.E.W. Wolstenholme, J. Knight. Elsevier, Amsterdam 1976; 135
- Knoll J. J. Neural Transm. 1978; 43: 177
- Knoll J., Ecseri Z., Kelemen K., Nievel J., Knoll B. Archs int. Pharmacodyn. Ther. 1965; 155: 154
- Lees A.J., Shaw K.M., Kohout L.J., Stern G.M., Elsworth J.D., Sandler M., Youdim M.B.H. Lancet 1977; ii: 791
- Lowhy O.H., Rosenbrough N.J., Farr A.L., Randall R.J. J. bio. Chem. 1951; 193: 565
- Omura T., Sato R. J. biol. Chem. 1964; 239: 370
- Philips S.R. J. Pharm. Pharmac. 1981; 33: 739
- Prough R.L., Ziegler D.M. Archs Biochem. Biophys. 1977; 180: 363
- Reynolds G.P., Elsworth J.D., Blau K., Sandler M., Lees A.J., Stern G.M. Br. J. Clin. Pharmac. 1978; 6: 542
- Terada Y., Yoshimura S., Yamamoto T., Yoshida T., Kuroiwa Y. Eisei Kagaku (J. Hyg. Chem., Tokyo) 1983; 29: 143
- Wurtman R.J., Axelrod J. Biochem. Pharmac. 1963; 12: 1439